Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from AspenBio Pharma, Inc.

< Previous 1 2 3 Next >
AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
Tickers APPY
From PR Newswire
AspenBio Pharma Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock
Tickers APPY
From PR Newswire
AspenBio Pharma Announces Proposed Public Offering
Tickers APPY
From PR Newswire
AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
Tickers APPY
From PR Newswire
AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
Company Remains on Track to Obtain CE Mark and Enroll First U.S. Patients Before Year End 
Tickers APPY
From PR Newswire
AspenBio Engages European-based Sales and Marketing Veteran Miquel Vernet to Consult on European Commercialization
Tickers APPY
From PR Newswire
AspenBio Pharma to Provide Third Quarter 2012 Business Update
Conference Call and Webcast scheduled for November 13, 2012, 4:30 p.m. ET 
Tickers APPY
From PR Newswire
AspenBio Proposes Corporate Name Change to Venaxis, Inc.
Tickers APPY
From PR Newswire
AspenBio Plans to Initiate Pivotal Study in Fourth Quarter
FDA Meeting Held; Advancing Toward Commercialization in U.S. and EU 
Tickers APPY
From PR Newswire
AspenBio to Provide Investors with Clinical and Business Update
Conference Call and Webcast scheduled for September 27, 2012, 8:30 a.m. ET 
Tickers APPY
From PR Newswire
AspenBio to Present at 2012 Aegis Healthcare Conference
Tickers APPY
From PR Newswire
AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
Tickers APPY
From PR Newswire
AspenBio to Present at Rodman & Renshaw Annual Global Investment Conference
Tickers APPY
From PR Newswire
AspenBio Pharma Focuses Resources on Development of AppyScore™ Clinical Diagnostic Test
To Provide Business Update Conference Call and Webcast Today at 5:00 p.m. ET 
Tickers APPY
From PR Newswire
AspenBio Pharma to Provide Shareholders with Business Update
Conference Call and Webcast scheduled for August 15, 2012, 5:00 p.m. ET 
Tickers APPY
From PR Newswire
AspenBio Pharma Submits Pre-IDE Information Package to FDA for AppyScore™ Appendicitis Test System
Company scheduled to meet FDA and receive feedback prior to end of third quarter 
Tickers APPY
From PR Newswire
AspenBio Pharma Enhances Product Development & Manufacturing Capabilities in Preparation for Clinical Trial and Commercialization of AppyScore™
Company engages diagnostics industry veteran, Lyndal Hesterberg, Ph.D., to spearhead production initiative 
Tickers APPY
From PR Newswire
AspenBio Pharma Notified by NASDAQ That It Regained Compliance With All NASDAQ Capital Market Continued Listing Standards
Tickers APPY
From Marketwired News Releases
AspenBio Pharma Announces Closing of Public Offering of 6,100,000 Shares of Common Stock
Tickers APPY
From Marketwired News Releases
AspenBio Pharma Announces Pricing of Public Offering of 6,100,000 Shares of Common Stock
Tickers APPY
From Marketwired News Releases
AspenBio Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial Officer
Tickers APPY
From Business Wire News Releases
Results of 503-Patient Clinical Study of AspenBio Pharma’s AppyScore™ Blood Test Show 97% Negative Predictive Value for Absence of Acute Appendicitis in Children and Adolescents Presenting with Abdomi
Tickers APPY
From Business Wire News Releases
Study Demonstrates AspenBio Pharma’s AppyScore Multi-Marker Blood Test Highly Predictive for Absence of Acute Appendicitis in Children with Abdominal Pain
Tickers APPY
From Business Wire News Releases
AspenBio Sets 2012 AppyScore Anticipated Milestones; Sees Pivotal Clinical Trial for Appendicitis Test Beginning Mid-2012
Following Major Portion of R&D Effort Completion and Expense Reductions, Cash Runway Extends to Advance 2012 Objectives 
Tickers APPY
From Marketwired News Releases
AspenBio Closes $1.6 Million Registered Direct Offering
Tickers APPY
From Marketwired News Releases
AspenBio Announces Registered Direct Offering of Approximately $1.6 Million
Tickers APPY
From Marketwired News Releases
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
Management to Host Conference Call at 5:00 PM ET Today 
Tickers APPY
From Marketwired News Releases
AspenBio Pharma to Report Results From Recently Completed AppyScore(TM) Pilot Study, Product Profile and Upcoming Milestones
Management to Host Conference Call on Monday, November 28, 2011 at 5:00 p.m. ET 
Tickers APPY
From Marketwired News Releases
AspenBio Awarded ISO 13485 Certification
Certification Milestone Is Required for Product Entry Into EU, Canada and Other Countries 
Tickers APPY
From Marketwired News Releases
AspenBio Reports Interim Data From AppyScore Pilot Study and Outlook for Regulatory Pathway
Management to Host Conference Call and Presentation Webcast at 4:30 PM ET Today 
Tickers APPY
From Marketwired News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.